Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 17/20 | 0.55 |
| ▸ | MELK | Q14680 | 1/20 | 0.45 |
| ▸ | ACP1 | P24666 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4370967 | 1.00 | FLT3 (0.55) | FLT3MELKACP1 | |
| SCHEMBL4886376 | 0.94 | FLT3 (0.50) | FLT3MELKACP1 | |
| SCHEMBL4886383 | 0.94 | FLT3 (0.50) | FLT3MELKACP1 | |
| SCHEMBL14167789 | 0.85 | FLT3 (0.56) | FLT3MELKACP1 | |
| SCHEMBL4885754 | 0.85 | FLT3 (0.41) | FLT3MELK | |
| SCHEMBL4369838 | 0.85 | FLT3 (0.41) | FLT3MELK | |
| SCHEMBL4364191 | 0.84 | FLT3 (0.44) | FLT3MELKACP1 | |
| SCHEMBL14167507 | 0.79 | FLT3 (0.51) | FLT3MELKACP1 | |
| SCHEMBL4365949 | 0.76 | MAPT (0.44) | FLT3 | |
| SCHEMBL4365944 | 0.76 | MAPT (0.44) | FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009046536-A1 | HALOGENATED QUINAZOLINYL NITROFURANS AS ANTIBACTERIAL AGENTS | ULYSSES PHARMACEUTICAL PRODUCTS, INC. (CA) | 2009-04-16 | — | — | WO | disclosed |
| US-20080146562-A1 | HALOGENATED QUINAZOLINYL NITROFURANS AS ANTIBACTERIAL AGENTS | ULYSSES PHARMACEUTICAL PRODUCTS INC., | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146562-A1 | HALOGENATED QUINAZOLINYL NITROFURANS AS ANTIBACTERIAL AGENTS | HRH3, HRH1, NQO2 | FLT3 1868/4885MELK 4706/4885ACP1 4375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.